Avalon GloboCare to launch KetoAir breathalyzer in UK starting Sept. 1.

• Avalon GloboCare to launch KetoAir breathalyzer in UK on Sept 1, 2025 • Device measures breath acetone concentration for ketogenic health management • Handheld device uses nano-sensor technology for real-time insights • Compatible with Apple and Android devices • Available for purchase at www.KetoAir.uk

Avalon GloboCare (NASDAQ: ALBT) has announced the launch of its KetoAir™ breathalyzer device in the United Kingdom, marking the company's first international market expansion for this product following its successful U.S. introduction. The device, which measures breath acetone concentration to track ketosis and fat metabolism, will be available for purchase starting September 1, 2025, through www.KetoAir.uk [1].

The KetoAir™ breathalyzer, manufactured by Qi Diagnostics Limited, utilizes nano-sensor technology to provide real-time insights into ketosis levels. This handheld device is compatible with both Apple and Android platforms, making it accessible to a wide range of smartphone users. The UK launch targets users pursuing ketogenic diets for weight management, athletic performance enhancement, or therapeutic purposes [1].

David Jin, M.D., Ph.D., President and Chief Executive Officer of Avalon GloboCare, expressed excitement about the expansion, stating, "We are excited to expand the availability of KetoAir™ into the UK. This launch builds on our U.S. market launch and represents an important step in growing our footprint. Amid the growing adoption of ketogenic and low-carb diets across the UK, we believe KetoAir™ is uniquely positioned to empower individuals in achieving their health and wellness goals" [1].

While the UK expansion represents a positive development for Avalon, several contextual factors temper its immediate impact. The announcement does not include distribution partnerships, retail placement, or projected revenue figures. Additionally, Avalon does not manufacture the device itself, suggesting it operates primarily as a distributor or marketing partner. The direct-to-consumer online sales model through a dedicated website (KetoAir.uk) indicates a focused but potentially limited distribution strategy. This approach allows Avalon to test market acceptance with minimal infrastructure investment while maintaining higher margins than traditional retail channels would permit [1].

The ketogenic monitoring device market faces competition from established players and alternative testing methods like blood and urine testing. Without disclosed pricing or comparative advantage details, it's difficult to assess KetoAir's competitive positioning in this specialized health tech segment. However, the device's compatibility with major smartphone platforms and its ability to deliver real-time insights could provide a competitive edge [1].

References:
[1] https://www.stocktitan.net/news/ALBT/avalon-globo-care-to-launch-online-sales-of-keto-air-breathalyzer-in-c3ytj1e0q2j0.html